Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

To Evaluate the Safety of Long-term Use of HPN-100 in the Management of Urea Cycle Disorders (UCDs)

ClinicalTrials.gov ID: NCT01257737

Public ClinicalTrials.gov record NCT01257737. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 21, 2026, 1:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Long Term Use of HPN-100 in Urea Cycle Disorders

Study identification

NCT ID
NCT01257737
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Amgen
Industry
Enrollment
88 participants

Conditions and interventions

Interventions

  • HPN-100 Drug

Drug

Eligibility (public fields only)

Age range
1 Year and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 3, 2010
Primary completion
Feb 15, 2017
Completion
Feb 15, 2017
Last update posted
Aug 21, 2024

2010 – 2017

United States locations

U.S. sites
15
U.S. states
13
U.S. cities
15
Facility City State ZIP Site status
UCLA Pediatrics/Genetics Los Angeles California 90095
Stanford University School of Medicine Palo Alto California 94305
Denver Children's Hospital Aurora Colorado 80045
Children's National Medical Center Washington D.C. District of Columbia 20010
Maine Medical Center Portland Maine 04102
University of Minnesota Medical Center Minneapolis Minnesota 55454
Mount Sinai School of Medicine New York New York 10029
University Hospitals Case Medical Center Cleveland Ohio 44106
Nationwide Children's Hospital Columbus Ohio 43205
Oregon Health & Science University Portland Oregon 97239
Children's Hospital of Pittsburg of UPMC Pittsburgh Pennsylvania 15224
Baylor College of Medicine Houston Texas 77030
University of Utah Salt Lake City Utah 84112
Seattle Children's Hospital Seattle Washington 98105
Children's Hospital of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01257737, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 21, 2024 · Synced May 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01257737 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →